Price
$43.61
Increased by +0.18%
Dollar Volume
2.99 M
ADR%
4.72
Earnings Report Date (estimate)
Mar 13, 23 (0.7)
Market Cap.
761.16 M
Shares Float
11.57 M
Shares Outstanding
17.45 M
Beta
1.04
Price / Earnings
-9.37
BPR
293.21
20D Range
38.50 44.86
50D Range
35.65 44.86
200D Range
22.31 44.86
  • Quarterly Earnings
  • Annual Earnings
Reported Date EPSChange YoY EstimateSurprise
Nov 9, 22 0.64
Decreased by -36.63%
0.55
Increased by +16.36%
Aug 8, 22 0.13
Decreased by -80.60%
0.22
Decreased by -40.91%
May 10, 22 -0.12
Decreased by -111.54%
0.09
Decreased by -233.33%
Mar 15, 22 0.54
Decreased by -32.50%
0.74
Decreased by -27.03%
Nov 1, 21 1.01
Increased by +4.12%
0.70
Increased by +44.29%
Aug 6, 21 0.67
Decreased by -2.90%
0.69
Decreased by -2.90%
May 7, 21 1.04
Increased by 0.00%
0.71
Increased by +46.48%
Mar 9, 21 0.80
Decreased by -25.93%
0.94
Decreased by -14.89%
  • Quarterly Financials
  • Annual Financials
Fiscal ending date RevenueChange YoY IncomeChange YoY ProfitChange YoY
Sep 30, 22 83.82 M
Increased by +61.01%
-9.01 M
Decreased by -102.52%
Decreased by -10.74%
Decreased by -25.78%
Jun 30, 22 73.86 M
Increased by +51.89%
-14.92 M
Decreased by -5.79%
Decreased by -20.21%
Increased by +30.35%
Mar 31, 22 64.48 M
Increased by +18.26%
-20.13 M
Decreased by -23.51 K%
Decreased by -31.22%
Decreased by -19.89 K%
Dec 31, 21 -39.76 M
Decreased by -169.44%
-51.05 M
Decreased by -1.30 K%
Increased by +128.39%
Increased by +2.12 K%
Sep 30, 21 52.06 M
Decreased by -1.73%
-4.45 M
Decreased by -1.12 K%
Decreased by -8.54%
Decreased by -1.14 K%
Jun 30, 21 48.63 M
Increased by +0.32%
-14.11 M
Decreased by -14.35%
Decreased by -29.01%
Decreased by -13.98%
Mar 31, 21 54.52 M
Increased by +9.54%
86.00 K
Increased by +101.23%
Increased by +0.16%
Increased by +101.12%
Dec 31, 20 57.25 M
Increased by +19.36%
-3.63 M
Increased by +24.82%
Decreased by -6.35%
Increased by +37.01%
  • Top 20 ETF Stock Exposure
  • Top 20 Institutional Holders
  • Top 20 Mutual Fund Holders
Rank ETF Shares Market Value Weight % in ETF
Open dropdown content
Open dropdown content
DAILY
WEEKLY
MONTHLY

ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose products; semi-solids, liquids, and topicals; and potent products, as well as performs contract development and manufacturing of pharmaceutical products for other companies. It markets its products through retail pharmacy chains, wholesalers, distributors and mail order pharmacies, and group purchasing organizations. The company was incorporated in 2001 and is headquartered in Baudette, Minnesota.